Product Information

IBUPROFEN 600 MG TABLET is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.0466 per EA under NDC 65162046510. Its NADAC has been published 412 times since Sep 12, 2018.

FDA first approved this application on Jun 18, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IBUPROFEN 600 MG TABLET

Ibuprofen
$0.0466per EA

Strength

600 mg/1

NDC

65162046510

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA078558

FDA Approved

6/18/2007

TE Code

AB

On Market Since

11/23/2009

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for IBUPROFEN 600 MG TABLET has been published 412 times since Sep 12, 2018, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0466 per EA
All-time high$0.0687 (Mar 11, 2020)
All-time low$0.0428 (Jul 17, 2024)
52-week high$0.0494
52-week low$0.0428
Median price$0.0560
Average price$0.0556
Largest weekly change+21.4% (Aug 21, 2024)
Weeks tracked412
Tracking sinceSep 12, 2018

Price History

1W

+6.0%

1M

+5.1%

3M

+5.1%

6M

+8.1%

1Y

-5.8%

3Y

-15.2%

5Y

-25.4%

All

-0.7%

Generic Alternatives

The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of IBUPROFEN 600 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 600 MG TABLET, manufactured by Amneal Pharmaceuticals LLC, is $0.0466 per EA (NDC 65162046510), effective Aug 19, 2026.

How has the price of IBUPROFEN 600 MG TABLET changed over time?

Over the history we have for it, the NADAC for IBUPROFEN 600 MG TABLET has held within roughly two percent of its current level. It has been tracked across 412 weekly CMS publications since Sep 12, 2018.

What are the highest and lowest recorded NADAC prices for IBUPROFEN 600 MG TABLET?

Since Sep 12, 2018, the NADAC for IBUPROFEN 600 MG TABLET has ranged from a low of $0.0428 (Jul 17, 2024) to a high of $0.0687 (Mar 11, 2020), with a median of $0.0560 per EA.

Are there cheaper alternatives to IBUPROFEN 600 MG TABLET?

Yes. 15 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 600 MG TABLET, is $0.0443 per EA — about 5% below IBUPROFEN 600 MG TABLET.

Who manufactures IBUPROFEN 600 MG TABLET?

IBUPROFEN 600 MG TABLET (NDC 65162046510) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.